Stock Scorecard



Stock Summary for BioNexus Gene Lab Corp (BGLC) - $0.29 as of 12/6/2024 7:13:03 PM EST

Total Score

15 out of 30

Safety Score

25 out of 100

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for BGLC

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BGLC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BGLC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BGLC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BGLC (25 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0

Latest News for for BGLC

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. - BioNexus Gene Lab ( NASDAQ:BGLC ) 9/25/2024 3:31:00 PM
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. 9/25/2024 3:31:00 PM
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. - BioNexus Gene Lab ( NASDAQ:BGLC ) 9/13/2024 4:05:00 PM
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. 9/13/2024 4:05:00 PM
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions 9/12/2024 5:23:00 PM
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production - BioNexus Gene Lab ( NASDAQ:BGLC ) 9/11/2024 3:05:00 PM
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production 9/11/2024 3:05:00 PM
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia ( MyCIF ) Co-Investment in Ascension Innovation Sdn Bhd - BioNexus Gene Lab ( NASDAQ:BGLC ) 8/27/2024 3:35:00 PM
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia ( MyCIF ) Co-Investment in Ascension Innovation Sdn Bhd 8/27/2024 3:35:00 PM
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd - BioNexus Gene Lab ( NASDAQ:BGLC ) 8/26/2024 4:15:00 PM

Financial Details for BGLC

Company Overview

Ticker BGLC
Company Name BioNexus Gene Lab Corp
Country USA
Description BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 0.29
Price 4 Years Ago 27.60
Last Day Price Updated 12/6/2024 7:13:03 PM EST
Last Day Volume 149,760
Average Daily Volume 1,042,589
52-Week High 1.57
52-Week Low 0.23
Last Price to 52 Week Low 26.09%

Valuation Measures

Trailing PE N/A
Industry PE 56.18
Sector PE 41.87
5-Year Average PE -34.62
Free Cash Flow Ratio 2.64
Industry Free Cash Flow Ratio 10.22
Sector Free Cash Flow Ratio 28.22
Current Ratio Most Recent Quarter 4.98
Total Cash Per Share 0.11
Book Value Per Share Most Recent Quarter 0.55
Price to Book Ratio 0.61
Industry Price to Book Ratio 1.95
Sector Price to Book Ratio 20.74
Price to Sales Ratio Twelve Trailing Months 0.59
Industry Price to Sales Ratio Twelve Trailing Months 1.80
Sector Price to Sales Ratio Twelve Trailing Months 24.57
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 17,967,700
Market Capitalization 5,210,633
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -95.00%
Annual Earnings Growth -638.57%
Reported EPS 12 Trailing Months -0.06
Reported EPS Past Year -0.07
Reported EPS Prior Year -0.16
Net Income Twelve Trailing Months -941,560
Net Income Past Year -2,629,043
Net Income Prior Year -355,966
Quarterly Revenue Growth YOY -23.10%
5-Year Revenue Growth 196.19%
Operating Margin Twelve Trailing Months 0.13

Balance Sheet

Total Cash Most Recent Quarter 2,061,716
Total Cash Past Year 2,623,965
Total Cash Prior Year 611,849
Net Cash Position Most Recent Quarter 2,061,716
Net Cash Position Past Year 2,623,965
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 9,657,852
Total Stockholder Equity Prior Year 6,665,013
Total Stockholder Equity Most Recent Quarter 9,388,173

Free Cash Flow

Free Cash Flow Twelve Trailing Months -2,500,922
Free Cash Flow Per Share Twelve Trailing Months -0.14
Free Cash Flow Past Year -1,301,613
Free Cash Flow Prior Year 497,651

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.02
MACD Signal -0.02
20-Day Bollinger Lower Band 0.26
20-Day Bollinger Middle Band 0.39
20-Day Bollinger Upper Band 0.52
Beta 1.87
RSI 49.06
50-Day SMA 6.75
150-Day SMA 0.00
200-Day SMA 10.15

System

Modified 12/6/2024 7:13:07 PM EST